Propofol limits rat myocardial ischemia and reperfusion injury with an associated reduction in apoptotic cell death in vivo

Vascular Pharmacology

Volumn 50, Issue 1-2, 2009, Pages 71-77

  Jin, Yong Chun ^a   Kim, WooYeol ^a   Ha, Yu Mi ^a   Shin, Il Woo ^b   Sohn, Ju Tae ^b   Kim, Hye Jung ^a   Seo, Han Geuk ^a   Lee, Jea Heun ^a   Chang, Ki Churl ^a  

^a Gyeongsang National University School of Medicine   (South Korea)

^b Gyeongsang National University   (South Korea)

Author keywords

Apoptosis; Myocardial I R injury; Propofol

Indexed keywords

CASPASE 3; DNA; GLUCOSE OXIDASE; INTRALIPID; PROPOFOL; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DNA STRAND BREAKAGE; DOSE RESPONSE; DRUG ACTIVITY; DRUG HALF LIFE; HEART MUSCLE ISCHEMIA; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY;

ANESTHETICS, INTRAVENOUS; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; HYPNOTICS AND SEDATIVES; IN SITU NICK-END LABELING; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; PROPOFOL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 57149098767     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2008.10.002     Document Type: Article

References (37)

1. Ambrosio G., Zweier J.L., Duilio C., Kuppusamy P., Santoro G., Elia P.P., Tritto I., Cirillo P., Condorelli M., Chiariello M., and John T. Evidence that mitochondrial respiration is a source of potentially toxic oxygen free radicals in intact rabbit hearts subjected to ischemia and reflow. J. Biol. Chem. 268 (1993) 18532-18541
2. Brocheriou V., Hagege A.A., Oubenaissa A., Lambert M., Mallet V.O., Druiez M., Wassef M., Kahn A., Menasche P., and Gilgenkrantz H. Cardiac functional improvement by a human Bcl-2 transgene in a mouse model of ischemia/reperfusion injury. J. Gene Med. 2 (2000) 326-333
3. Bryson H.M., Fulton B.R., and Faulds D. Propofol: an update of its use in anesthesia and conscious sedation. Drugs 50 (1995) 513-559
4. Calvillo L., Masson S., Salio M., Pollicino L., De Angelis N., Fiordaliso F., Bai A., Ghezzi P., Santangelo F., and Latini R. In vivo cardioprotection by N-acetylcysteine and isosorbide 5-mononitrate in a rat model of ischemia-reperfusion. Cardiovasc. Drugs Ther. 17 (2003) 199-208
5. Chen M., He H., Zhan S., Krajewski S., Reed J.G., and Gottlieb R.A. Bid is cleaved by calpain to an active fragment in vitro and during myocardial ischemia/reperfusion. J. Biol. Chem. 276 (2001) 30724-30728
6. Crow M.T., Mani K., Nam Y.J., and Kitsis R.N. The mitochondrial death pathway and cardiac myocyte apoptosis. Circ. Res. 95 (2004) 957-970
7. Depre C., Kim S.J., John A.S., Huang Y., Rimoldi O.E., Pepper J.R., Dreyfus G.D., Gaussin V., Penell D.J., Vatner D.E., Camici P.G., and Vatner S.F. Program of cell survival underlying human and experimental hibernating myocardium. Circ. Res. 95 (2004) 433-540
8. Engelhard K., Werner C., Eberspacher E., Pape M., Stegemann U., Kellermann K., Hollweck R., Hutzler P., and Kochs E. Influence of propofol on neuronal damage and apoptotic factors after incomplete cerebral ischemia and reperfusion in rats: a long-term observation. Anesthesiology 101 (2004) 912-917
9. Gottlieb R.A., and Engler R.L. Apoptosis in myocardial ischemia-reperfusion. Ann. N. Y. Acad. Sci. 874 (1999) 412-426
10. Guide for the care and use of laboratory animals, 1996. Institute of laboratory animal resources, commission on life sciences, National research council, National academy press, Washington DC.
11. Gulcin I., Ahmet H.A., and Cesur M. Determination of in vitro antioxidant and radical scavenging activities of propofol. Chem. Pharm. Bull. 53 (2005) 281-285
12. Gustafsson A.B., and Gottlieb R.A. Mechanisms of apoptosis in the heart. J. Clin. Immunol. 23 (2003) 447-459
13. Halestrap A.P., Clarke S.J., and Javadov S.A. Mitochondrial permeability transition pore opening during myocardial reperfusion-a target for cardioprotection. Cardiovasc. Res. 61 (2004) 372-385
14. Haunstetter A., and Izumo S. Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ. Res. 82 (1998) 1111-1129
15. Huang J., Nakamura K., Ito Y., Uzuka T., Morikawa M., Hirai S., Tomihara K., Tanaka T., Masuta Y., Ishii K., Kato K., and Hamada H. Bcl-xL gene transfer inhibits Bax translocation and prolongs cardiac cold preservation time in rats. Circulation 112 (2005) 76-83
16. Imahashi K., Schneider M.D., Steenbergen C., and Murphy E. Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia/reperfusion injury. Circ. Res. 95 (2004) 734-741
17. Jin Y.C., Kim K.J., Kim Y.M., Ha Y.M., Kim H.J., Yun E.J., Bae K.H., Kim Y.S., Kang S.S., Seo H.G., Lee J.H., and Chang K.C. Anti-apoptotic effect of magnolol in myocardial ischemia and reperfusion injury requires extracellular signal-regulated kinase1/2 pathways in rat in vivo. Exp. Biol. Med. 233 (2008) 1280-1288
18. Kato R., and Foex P. Myocardial protection by anesthetic agents against ischemia- reperfusion injury: an update for anesthesiologists. Can. J. Anaesth. 49 (2002) 777-791
19. Kobayashi I., Kokita N., and Namiki A. Propofol attenuates ischaemia-reperfusion injury in the rat heart in vivo. Eur. J. Anaesthesiol. 25 (2008) 144-151
20. Kokita N., and Hara A. Propofol attenuates hydrogen-peroxide induced mechanical and metabolic derangements in the isolated rat heart. Anesthesiology 84 (1996) 117-127
21. Kokita N., Hara A., Abiko Y., Arakawa J., Hashizume H., and Namiki A. Propofol improves functional and metabolic recovery in ischemic reperfused isolated rat hearts. Anesth. Analg. 86 (1998) 252-258
22. Ko S.H., Yu C.W., Lee S.K., Choe H., Chung M.J., Kwak Y.G., Chae S.W., and Song H.S. Propofol attenuates ischemia-reperfusion injury in the isolated rat heart. Anesth. Analg. 85 (1997) 719-724
23. Lee Y.S., Kang Y.J., Kim H.J., Park M.K., Seo H.G., Lee J.H., Yun-Choi H.S., and Chang K.C. Higenamine reduces apoptotic cell death by induction of hemeoxygenase-1 in rat myocardial ischemia-reperfusion injury. Apoptosis 11 (2006) 1091-1100
24. Levraut J., Iwase H., Shao Z.H., Vanden Hoek T.L., and Schumacker P.T. Cell death during ischemia: relationship to mitochondrial depolarization and ROS generation. Am. J. Physiol. Heart Circ. Physiol. 284 (2003) H549-H558
25. Lundberg K.C., and Szweda L.I. Initiation of mitochondrial-mediated apoptosis during cardiac reperfusion. Arch. Biochem. Biophys. 432 (2004) 50-57
26. Murphy P.G., Myers D.S., Davies M.J., Webster N.R., and Jones J.G. The antioxidant potential of propofol (2, 6-diisopropylphenol). Br. J. Anaesth. 68 (1992) 613-618
27. Narula J., Haider N., Virmani R., Disalve T.G., Kolodgie F.D., Hajjar R.J., Schmidt U., Semigraan M.J., Dec D.W., and Khaw B.A. Apoptosis in myocytes in end-stage heart failure. N. Engl. J. Med. 335 (1996) 1182-1189
28. Nizamutdinova I.T., Jin Y.C., Kim J.S., Yean M.H., Kang S.S., Kim Y.S., Lee J.H., Seo H.G., Kim H.J., and Chang K.C. Paeonol and paeoniflorin, the main active principles of Paeonia albiflora, protect the heart from myocardial ischemia/reperfusion injury in rats. Planta Med. 74 (2008) 14-18
29. Nolan A., and Reid J. Pharmacokinetics of propofol administered by infusion in dogs undergoing surgery. Br. J. Anaesth. 70 (1993) 546-551
30. Olivetti G., Abbi R., Quaini F., Kajstura J., Cheng W., Nitahara J.A., Quaini E., Di Loreto C., Beltrami C.A., krajewski S., Reed J.C., and Anversa P. Apoptosis in the failing human heart. N. Engl. J. Med. 336 (1997) 1131-1141
31. Reimer K.A., and Jennings R.B. Myocardial ischemia, hypoxia and infarction. In: Fozzard H.A., Haber E., Jennings R.B., Katz A.M., and Morgan H.E. (Eds). The Heart and Cardiovascular System (1992), Raven Press, New York 1875-1973
32. Runzer T.D., Ansley D.M., Godin D.V., and Chambers G.K. Tissue antioxidant capacity during anesthesia: propofol enhances in vivo red cell and tissue antioxidant capacity in a rat model. Anesth. Analg. 94 (2002) 89-93
33. Scarabelli T.M., knight R.A., Rayment N.B., Cooper T.J., Stephanou A., Brar B.K., Lawrence K.M., Santilli G., Latcman D.S., Baxter G.F., and Yellon D.M. Quantitative assessment of cardiac myocyte apoptosis in tissue sections using the fluorescence-based TUNEL technique enhanced with counterstains. J. Immunol. Methods 228 (1999) 23-28
34. Singal P.K., Dhalla A.K., Hill M., and Thomas I.P. Endogenous antioxidant changes in the myocardium in response to acute and chronic stress conditions. Mol. Cell. Biochem. 129 (1993) 179-186
35. Vanden Hoek T.L., Becker L.B., Shao Z., Li C., and Schumacker P.T. Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J. Biol. Chem. 273 (1998) 18092-18098
36. Xia Z.Y., Godin D.V., Chang T.K.H., and Ansley D.M. Dose-dependent protection of cardiac function by propofol during ischemia and early reperfusion in rats: effects on 15-F-2t-isoprostane formation. Can. J. Physiol. Pharm. 81 (2003) 14-21
37. Zweier J.L., Flaherty J.T., and Weisfeldt M.L. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc. Natl. Acad. Sci. USA 4 (1987) 1404-1407